Altox

Database / API & reference standards

API & reference standards

Ceritinib

Ceritinib is listed in the API and reference-standard collection under CAS 1032900-25-6. Its represented structure has formula C28H36ClN5O3S and a calculated molecular weight of 558.15 g/mol.

2D chemical structure

N H N C l N H S O O N O H N

Chemical identity

Catalog name
Ceritinib
Common name
Ceritinib
Chemical name
5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine
CAS
1032900-25-6
SMILES
Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1
InChI
InChI=1S/C28H36ClN5O3S/c1-17(2)37-25-15-21(20-10-12-30-13-11-20)19(5)14-24(25)33-28-31-16-22(29)27(34-28)32-23-8-6-7-9-26(23)38(35,36)18(3)4/h6-9,14-18,20,30H,10-13H2,1-5H3,(H2,31,32,33,34)
InChIKey
VERWOWGGCGHDQE-UHFFFAOYSA-N
Associated API
Ceritinib

Record ID: A4da01f28cc6c

Computed properties

C28H36ClN5O3S Molecular formula
558.148 g/molMolecular weight
557.2227 DaMonoisotopic exact mass
105.24 ŲTopological polar surface area
6.3619 Calculated LogP (Wildman–Crippen)
154.1589 cm³/molMolar refractivity (Wildman–Crippen)
8 countHydrogen-bond acceptors
3 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 3 6 9 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl H N O S 0 8 16 24 32 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight558.14889.71
Calculated LogP (Wildman–Crippen)6.361995.75
Topological polar surface area105.2475.09
Hydrogen-bond acceptors887.87
Hydrogen-bond donors381.39
Rotatable bonds (strict)986.25

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC28H36ClN5O3Sdimensionless
Molecular weight558.148g/mol
Monoisotopic exact mass557.2227Da
Topological polar surface area105.24Ų
Calculated LogP (Wildman–Crippen)6.3619dimensionless
Molar refractivity (Wildman–Crippen)154.1589cm³/mol
Hydrogen-bond acceptors8count
Hydrogen-bond donors3count
Rotatable bonds (strict)9count
Heavy atoms38count
Heteroatoms10count
Rings4count
Aromatic rings3count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles1count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.4286fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area230.0502Ų
Valence electrons204count
Radical electrons0count
Bertz complexity1,389.2316index
Balaban J1.6602index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Ceritinib

PDE, HBEL and impurity assessment for Ceritinib

For a substance-specific assessment, request a PDE report for Ceritinib or explore HBEL derivation for Ceritinib. These services address exposure limits using toxicological evidence and the intended use of the substance.

For pharmaceutical development, explore prediction of degradation products of Ceritinib and qualification of impurities related to Ceritinib.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Ceritinib

Explore Altox services and software through the Altox Pharma-Hub.